Literature DB >> 25655343

Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PET.

Bradley J Carra1, Michael N Clemenshaw2.   

Abstract

Leptomeningeal carcinomatosis is an uncommon manifestation of non-central nervous system (CNS) metastatic disease. Diagnosis, however, has important prognostic and treatment implications. We present a case in which intracranial leptomeningeal carcinomatosis from a primary breast cancer was detected with (18)F-FDG PET/CT, despite its low sensitivity for detection of CNS metastases from non-CNS primary tumors.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  18F-FDG PET/CT; breast cancer; leptomeningeal carcinomatosis

Mesh：

Substances：

Year:  2015        PMID： 25655343     DOI： 10.2967/jnmt.114.148791

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN： 0091-4916


  4 in total

1.  Determination of the Estrogen Receptor Status of Leptomeningeal Metastasis in Patients with Metastatic Breast Cancer Using [18F]-FES PET/CT: a Case Report.

Authors:  Jeongryul Ryu; Jae Ho Jeong; Dae Hyuk Moon; Dong Yun Lee
Journal:  Nucl Med Mol Imaging       Date:  2022-01-28

2.  Characteristics of Patients with Meningeal Carcinomatosis Combined with Myelopathy.

Authors:  Lidong Jiao; Min Wei; Yongjuan Fu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-05-19       Impact factor: 2.989

3.  Intracranial Leptomeningeal Carcinomatosis in Three Cases from Breast Cancer Demonstrated on F-18 Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography.

Authors:  Hulya Ortapamuk; Mustafa Kemal Demir
Journal:  Indian J Nucl Med       Date:  2017 Jan-Mar

4.  Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Authors:  Susanna Nuvoli; Silvia Contu; Bi Llie Joy Pung; Patrizia Solinas; Giuseppe Madeddu; Angela Spanu
Journal:  Case Rep Neurol       Date:  2018-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.